First Volunteer Receives Potential Ebola Vaccine In Safety Trial

September 17, 2014 8:40 PM

30 0

A 48-year-old communications and engagement manager in the UK's National Health Service became the first volunteer to receive a candidate Ebola vaccine today in a safety trial. The vaccine is currently being developed by GlaxoSmithKline and the U.S. National Institutes of Health.

The woman, Ruth Atkins, is one of 60 volunteers to participate in the trial, which is being conducted by researchers at the University of Oxford. She received the vaccine this morning (Sept. 17).

Read more

To category page